Next Article in Journal
Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand
Next Article in Special Issue
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors
Previous Article in Journal
Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy
Previous Article in Special Issue
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(1), 23; https://doi.org/10.3390/pharmaceutics16010023
Action Date Notes Link
article xml file uploaded 22 December 2023 16:06 CET Original file -
article xml uploaded. 22 December 2023 16:06 CET Update -
article pdf uploaded. 22 December 2023 16:06 CET Version of Record https://www.mdpi.com/1999-4923/16/1/23/pdf
article html file updated 22 December 2023 16:09 CET Original file -
article xml file uploaded 22 December 2023 16:15 CET Update -
article xml uploaded. 22 December 2023 16:15 CET Update https://www.mdpi.com/1999-4923/16/1/23/xml
article html file updated 22 December 2023 16:16 CET Update https://www.mdpi.com/1999-4923/16/1/23/html
Back to TopTop